Pluri Inc.
Biotechnology firm with 3D cell-expansion tech for manufacturing cell-based products.
PLUR | TA
Overview
Corporate Details
- ISIN(s):
- US72942G2030
- LEI:
- Country:
- Israel
- Address:
- Park Building No. 5, 3508409 Haifa
- Website:
- https://pluri-biotech.com/
- Sector:
- Manufacturing
Description
Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-10 01:38 |
FORM S-8-REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933??
|
English | 36.3 KB | ||
| 2024-05-10 01:36 |
FORM S-REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 193
|
English | 156.4 KB | ||
| 2024-05-10 01:36 |
FORM S-REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 193
|
English | 36.3 KB | ||
| 2024-05-10 01:26 |
Form 10Q -For the quarterly period ended March 31, 2024
|
English | 339.0 KB | ||
| 2024-05-10 01:26 |
Form 10Q -For the quarterly period ended March 31, 2024
|
English | 36.5 KB | ||
| 2024-05-02 16:01 |
Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
|
English | 96.7 KB | ||
| 2024-05-02 16:01 |
Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
|
English | 36.2 KB | ||
| 2024-05-01 17:45 |
2023 Annual Report
|
English | 504.3 KB | ||
| 2024-05-01 17:45 |
2023 Annual Report
|
English | 36.3 KB | ||
| 2024-05-01 17:42 |
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held On June 25, 2024
|
English | 2.0 MB | ||
| 2024-05-01 17:42 |
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held On June 25, 2024
|
English | 110.7 KB | ||
| 2024-04-17 16:12 |
Received a notification letter from Nasdaq notifying the Company that it had re…
|
English | 110.0 KB | ||
| 2024-04-17 16:12 |
Received a notification letter from Nasdaq notifying the Company that it had re…
|
English | 36.2 KB | ||
| 2024-04-08 16:01 |
Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method
|
English | 90.0 KB | ||
| 2024-04-08 16:01 |
Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method
|
English | 36.2 KB |
Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pluri Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pluri Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
